MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Orthofix taps ex-AMS finance chief Heggestad to be new CFO

Orthofix taps ex-AMS finance chief Heggestad to be new CFO

By

Orthofix taps ex-AMS finance chief Heggestad to be new CFO

Orthofix (NSDQ:OFIX) named the former CFO for American Medical Systems, Mark Heggestad, to be its new finance chief.

Last month Orthofix named David Ziegler, an outside consultant who’s been helping with a massive audit of the orthopedic device maker’s books, as interim CFO to replace Emily Buxton.

Buxton’s decade-long tenure at Orthofix, originally slated to end May 14, will now end "on or about" May 9 when Heggestad takes over, according to a press release.

"We are excited to welcome Mark to the Orthofix team," president & CEO Brad Mason said in prepared remarks. "There is a lot to do in the next few years to become best in class in our finance and business processes. I believe Mark will be a great partner to the executive team and me in leading these efforts and that he will keep the company focused on the key initiatives that will drive shareholder value."

Ziegler will stay on to assist with Heggestad’s transition and "continue to provide consulting services," Orthofix said.

 Alphatec names medtech vet Corbett as new CEO, cans ops SVP

Alphatec (NSDQ:ATEC) said it named a new president & CEO, Baxter (NYSE:BAX) and Boston Scientific (NYSE:BSX) veteran James Corbett, to take over the corner office from Leslie Cross effective May 1.

Alphatec also said it eliminated its U.S. commercial operations senior vice president role held by Thomas McLeer and announced the resignation of Luke Faulstick from its board.
Read more

 Ex-Nokia exec Savander takes helm at Elekta
Elekta (STO:EKTA B) said its choice for CEO, former Nokia executive Niklas Savander,, officially took the Swedish imaging company’s helm May 1. Elekta announced in October 2013 that Savander would succeed Tomas Puusepp, who kept his seat on Stockholm-based company’s board.
Read more

 BSD Medical announces CEO succession plan

BSD Medical Corp. (NSDQ:BSDM) said president & CEO Harold "Butch" Wolcott agreed to cede the corner office to an as-yet-unnamed successor, but will continue leading the company while the search goes on. Wolcott is slated to remain on the BSD Medical board after the CEO succession.
Read more

 EndoGastric Solutions names Given Imaging’s Baldino as new CEO
EndoGastric Solutions, which earlier this year paid $5 million to settle federal Medicare fraud charges, said it named Skip Baldino, former Americas president for Covidien (NYSE:COV) buyout Given Imaging, to be its president and CEO.
Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • GE Healthcare picks AI imaging startups for inaugural Edison Accelerator
    GE Healthcare and Nex Cubed have selected seven companies focused on artificial-intelligence-augmented medical imaging for the first cohort of the Edison Accelerator in Canada. The companies will be matched with mentors and test their technologies with GE’s new Edison Digital Health Platform over the next three months. The program will end with innovation showcase presentations… […]
  • Boston Scientific whistleblower launches corruption investigation
    Boston Scientific (NYSE:BSX) is investigating claims that the company violated the U.S. Foreign Corrupt Practices Act in Vietnam. Marlborough, Massachusetts–based Boston Scientific disclosed receipt of a whistleblower’s allegations in its latest filing with the Securities and Exchange Commission. “In March 2022, the company received a whistleblower letter alleging Foreign Corrupt Practices Act violations in Vietnam.… […]
  • 5 essential leadership lessons from Cathy Burzik for medtech’s next generation of women leaders
    Cathy Burzik, a seasoned senior executive in the healthcare industry, has successfully led major medical device, diagnostic, diagnostic imaging and life sciences businesses. Cathy Burzik, CFB Interests (as told to MedExecWomen co-founder Maria Shepherd) One key to being a successful women leader in MedTech: “Play nice, but play to win.” Cathy Burzik, who received a… […]
  • Stratasys plans to buy Covestro’s additive manufacturing business
    Stratasys (Nasdaq:SSYS) said today that it has a deal to purchase the additive manufacturing materials business of Covestro. The deal includes R&D facilities and activities, global development and sales teams across Europe, the U.S. and China, a portfolio of approximately 60 additive manufacturing materials, and hundreds of patents and patents pending, Stratasys said in a… […]
  • New implant design prevents scar tissue without drugs, MIT says
    Mechanically inflating and deflating an implantable device for 10 minutes a day prevents immune cells from building the scar tissue that has been a major obstacle for artificial pancreas researchers. That’s according to new findings from a team of MIT engineers who built mechanical deflection into a two-chambered, soft polyurethane device tested on mice. By… […]
  • Blue Spark’s TempTraq catches fevers faster. Fever prediction is next.
    Blue Spark Technologies developed the first wireless continuous temperature monitor patch, TempTraq, to enable faster fever detection than standard manual readings every four hours. Westlake, Ohio-based Blue Spark is now looking at fever prediction rather than just detecting them. The R&D team is working on developing an AI neural network model built on the company’s… […]
  • Harvard researchers plan to sell at-home, PCR-grade COVID testing system
    The Harvard University researchers who developed an ultrasensitive, PCR-grade nucleic acid detection technology plan to commercialize it as a portable COVID-19 test. Harvard Medical School professor Peng Yin, who also leads the Wyss Institute for Biologically Inspired Engineering’s Molecular Robotics Initiative, founded 3EO Health to sell the device. “In order to optimize the value of… […]
  • FDA reports sterilization challenge progress as EPA takes aim at EtO emissions
    The FDA offered an update on its efforts to make medical device sterilization safer as the EPA identified 23 U.S. facilities where use of ethylene oxide (EtO) presents a risk to communities. The FDA said it is similarly concerned about unsafe EtO emissions and highlighted work with the medical device industry to reduce EtO usage… […]
  • AdvaMed defends EtO facilities on EPA’s cancer risk list
    The Advanced Medical Technology Association (AdvaMed) today reacted to the EPA’s listing of commercial sterilization facilities causing elevated risks of cancer with a defense of the facilities and a call for more research. AdvaMed CEO and President Scott Whitaker said all of the listed facilities are in compliance with regulations and warned against closures. “The… […]
  • EPA flags high-cancer-risk EtO sterilization facilities across the country
    The EPA today identified nearly two dozen U.S. cities where commercial sterilizers using ethylene oxide (EtO) contribute to an elevated cancer risk for residents of surrounding communities. EtO is used on about 20 billion medical devices each year — or about half of all sterile medical devices —  and in some cases it’s the only… […]
  • New method of cardiac ablation used in first in-human trial for ventricular tachycardia
    A new cardiac ablation technique for patients with ventricular tachycardia (VT) has been used in its first in-human multicenter trial involving Mayo Clinic. The new process — needle ablation using in-catheter, heated, saline-enhanced, radio frequency (SERF) energy — creates lesion scars inside the heart muscle where life-threatening arrhythmias cause VT, Mayo Clinic said. Injecting heated saline… […]

Leave a Reply